Pushback on costly #drugs
http://CEN.acs.org/articles/95/i9/Pushback.html Table of signpost meds: $80k Sovaldi hep. C treatment, $14k/yr for PCSK9 inhibitor Repatha
Posts Tagged ‘pcsk9’
Costly drugs | February 27, 2017 Issue – Vol. 95 Issue 9 | Chemical & Engineering News
March 25, 2017Cholesterol-Lowering PCSK9 Inhibitors Near Market Entry | March 30, 2015 Issue – Vol. 93 Issue 13 | Chemical & Engineering News
April 11, 2015#PCSK9 Inhibitors Near Market Entry
http://cen.acs.org/articles/93/i13/Cholesterol-Lowering-PCSK9-Inhibitors-Near.html Suggested by natural #LOF lowering LDL via promoting recycling of its receptor
linkstream2 microblog 